Update on the therapeutic management of patients with either psoriatic arthritis or ulcerative colitis: focus on the JAK inhibitor tofacitinib

Psoriatic arthritis (PsA) and ulcerative colitis (UC) are immune-mediated diseases that cause significant burden worldwide. Recent advances in their management have improved patient outcomes. However, significant unmet needs still remain as not all patients respond to current treatments, and patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Chimenti, Maria Sole, Conigliaro, Paola, Biancone, Livia, Perricone, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897839/
https://www.ncbi.nlm.nih.gov/pubmed/33680096
http://dx.doi.org/10.1177/1759720X20977777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897839/
https://www.ncbi.nlm.nih.gov/pubmed/33680096
http://dx.doi.org/10.1177/1759720X20977777

Ejemplares similares